UB Paderborn / Katalog / Suche / in CDI

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

Arthritis research & therapy, 2020-10, Vol.22 (1), p.250-250, Article 250

2020

Volltextzugriff (PDF)

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

Arthritis research & therapy, 2020-04, Vol.22 (1), p.70-11, Article 70

2020

Volltextzugriff (PDF)

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan

Rheumatology and therapy., 2020-09, Vol.7 (3), p.517-535

2020

Volltextzugriff (PDF)

Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia

The American journal of cardiology, 2018-05, Vol.121 (10), p.1155-1161

2018

Volltextzugriff (PDF)

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

BMC cancer, 2016-07, Vol.16 (1), p.564-564, Article 564

2016

Volltextzugriff (PDF)

Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence

Journal of managed care & specialty pharmacy, 2019-10, Vol.25 (10), p.1053

2019

Volltextzugriff (PDF)

Risk of Incident Atherosclerotic Cardiovascular Disease Events by Achieved Atherogenic Lipid Levels Among 62,428 Statin-Treated Individuals With Diabetes Mellitus

The American journal of cardiology, 2018-09, Vol.122 (5), p.762

2018

Volltextzugriff (PDF)

Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions

Cardiovascular drugs and therapy, 2018-06, Vol.32 (3), p.273-280

2018

Volltextzugriff (PDF)

Trends in Statin Use 2009–2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol

Cardiovascular drugs and therapy, 2018-08, Vol.32 (4), p.397-404

2018

Volltextzugriff (PDF)

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease

PharmacoEconomics, 2018-01, Vol.36 (1), p.115-126

2018

Volltextzugriff (PDF)

Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus

The American journal of cardiology, 2018-09, Vol.122 (5), p.762-767

2018

Volltextzugriff (PDF)

Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults

American health & drug benefits, 2019-06, Vol.12 (4), p.202-211

2019

Volltextzugriff (PDF)

Trends in Lipid Screening Among Adults in an Integrated Health Care Delivery System, 2009-2015

Journal of managed care & specialty pharmacy, 2018-11, Vol.24 (11), p.1090

2018

Volltextzugriff (PDF)

TRENDS IN STATIN USE AMONG ADULTS IN AN INTEGRATED HEALTH CARE DELIVERY SYSTEM: IMPACT OF THE 2013 GUIDELINE ON THE TREATMENT OF BLOOD CHOLESTEROL

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1694-1694

2017

Volltextzugriff (PDF)

Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence

Patient preference and adherence, 2016-01, Vol.10 (Issue 1), p.1025-1035

2016

Volltextzugriff (PDF)

Identification of Patients with Statin Intolerance in a Managed Care Plan: A Comparison of 2 Claims-Based Algorithms

Journal of managed care & specialty pharmacy, 2017-09, Vol.23 (9), p.926

2017

Volltextzugriff (PDF)

Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States

Patient preference and adherence, 2016-01, Vol.10 (Issue 1), p.45-55

2016

Volltextzugriff (PDF)

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies

ClinicoEconomics and outcomes research, 2018-01, Vol.10, p.805-819

2018

Volltextzugriff (PDF)

Total costs and atrial fibrillation ablation success or failure in medicare-aged patients in the United States

Advances in therapy, 2010-09, Vol.27 (9), p.600-612

2010

Volltextzugriff (PDF)

15117 Quality of life impact in adolescent patients with moderate to severe atopic dermatitis: Screening data from the LIBERTY AD ADOL trial

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB29-AB29

2020

Volltextzugriff (PDF)

Cost-effectiveness analysis of universal noninvasive testing for post-treatment confrmation of Helicobacter pylori eradication and the impact of patient adherence

Patient preference and adherence, 2020-03, p.1025

2020

Volltextzugriff (PDF)

Treatment and characteristics of patients treated for hepatocellular carcinoma (HCC) by physician types in the United States

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.375-375

2012

Volltextzugriff (PDF)

Treatment patterns and cost for colorectal cancer by line of therapy and metastasis status

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e14658-e14658

2013

Volltextzugriff (PDF)

Prognostic significance of hypervolemic or euvolemic hyponatremia in patients with lymphoma, breast, lung, or colorectal cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17554-e17554

2015

Volltextzugriff (PDF)

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]

ClinicoEconomics and outcomes research, 2019-01, Vol.11, p.83-85

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan

Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence

Risk of Incident Atherosclerotic Cardiovascular Disease Events by Achieved Atherogenic Lipid Levels Among 62,428 Statin-Treated Individuals With Diabetes Mellitus

Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions

Trends in Statin Use 2009–2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease

Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus

Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults

Trends in Lipid Screening Among Adults in an Integrated Health Care Delivery System, 2009-2015

TRENDS IN STATIN USE AMONG ADULTS IN AN INTEGRATED HEALTH CARE DELIVERY SYSTEM: IMPACT OF THE 2013 GUIDELINE ON THE TREATMENT OF BLOOD CHOLESTEROL

Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence

Identification of Patients with Statin Intolerance in a Managed Care Plan: A Comparison of 2 Claims-Based Algorithms

Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies

Total costs and atrial fibrillation ablation success or failure in medicare-aged patients in the United States

15117 Quality of life impact in adolescent patients with moderate to severe atopic dermatitis: Screening data from the LIBERTY AD ADOL trial

Cost-effectiveness analysis of universal noninvasive testing for post-treatment confrmation of Helicobacter pylori eradication and the impact of patient adherence

Treatment and characteristics of patients treated for hepatocellular carcinoma (HCC) by physician types in the United States

Treatment patterns and cost for colorectal cancer by line of therapy and metastasis status

Prognostic significance of hypervolemic or euvolemic hyponatremia in patients with lymphoma, breast, lung, or colorectal cancer

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]

Suchergebnisse filtern